Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Pfizer Signs Deal With Allogene To Develop Cancer Cell Therapy
LPNEWS

Pfizer Signs Deal With Allogene To Develop Cancer Cell Therapy

by reuters.com posted 11months ago 33 views
April 3 (Reuters) - Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy.

In this article